Related references
Note: Only part of the references are listed.Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
Julius Pollinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies
Zied Gaieb et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
Allosteric modulation of the farnesoid X receptor by a small molecule
Matthias Gabler et al.
SCIENTIFIC REPORTS (2018)
Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro
Pascal Heitel et al.
SCIENTIFIC REPORTS (2018)
Nonacidic Farnesoid X Receptor Modulators
Daniel Flesch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Novel Class of Natural FXR Modulators with a Unique Mode of Selective Co-regulator Assembly
Weili Zheng et al.
CHEMBIOCHEM (2017)
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound
Christina Lamers et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Anthranilic acid derivatives as nuclear receptor modulators-Development of novel PPAR selective and dual PPAR/FXR ligands
Daniel Merk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Bile Acids as Hormones: The FXR-FGF15/19 Pathway
Steven A. Kliewer et al.
DIGESTIVE DISEASES (2015)
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2015)
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia
Michael J. Genin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Advances in our structural understanding of orphan nuclear receptors
Nerea Gallastegui et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Nuclear receptor full-length architectures: confronting myth and illusion with high resolution
Fraydoon Rastinejad et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
Lihua Jin et al.
SCIENTIFIC REPORTS (2015)
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
Daniel Merk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Christina Lamers et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Extending the Structure-Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
Daniel Merk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
Lihua Jin et al.
NATURE COMMUNICATIONS (2013)
Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
Ramona Steri et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS
Michael Krug et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2012)
Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin
Uwe Mueller et al.
JOURNAL OF SYNCHROTRON RADIATION (2012)
Data processing and analysis with the autoPROC toolbox
Clemens Vonrhein et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
Adwoa Akwabi-Ameyaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation
Stephen M. Soisson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene
Sabine Seuter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma
Oliver Rau et al.
PLANTA MEDICA (2006)
FK614, a novel peroxisome proliferator-activated receptor γ modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators
T Fujimura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Structural basis for bile acid binding and activation of the nuclear receptor FXR
LZ Mi et al.
MOLECULAR CELL (2003)
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR
M Downes et al.
MOLECULAR CELL (2003)
Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump
J Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
M Ananthanarayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nuclear hormone receptors and gene expression
A Aranda et al.
PHYSIOLOGICAL REVIEWS (2001)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
